ofloxacin has been researched along with phenylalanine arginine beta-naphthylamide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blais, J; Chamberland, S; Cho, D; Fronko, R; Galazzo, J; Hecker, S; Hoshino, K; Ishida, H; Lee, A; Lee, M; Lee, VJ; Leger, R; Lomovskaya, O; Renau, T; Warren, MS; Watkins, W | 1 |
Coban, AY; Durupinar, B; Ekinci, B | 1 |
Izard, D; Mullié, C; Sonnet, P | 1 |
3 other study(ies) available for ofloxacin and phenylalanine arginine beta-naphthylamide
Article | Year |
---|---|
Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.
Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; Carrier Proteins; Cephalosporins; Dipeptides; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Escherichia coli; Levofloxacin; Magnetic Resonance Spectroscopy; Membrane Transport Proteins; Microbial Sensitivity Tests; Ofloxacin; Plasmids; Pseudomonas aeruginosa | 2001 |
A multidrug efflux pump inhibitor reduces fluoroquinolone resistance in Pseudomonas aeruginosa isolates.
Topics: Bacterial Outer Membrane Proteins; Ciprofloxacin; Dipeptides; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Levofloxacin; Membrane Transport Modulators; Membrane Transport Proteins; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa | 2004 |
Prevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dipeptides; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Membrane Transport Proteins; Microbial Sensitivity Tests; Ofloxacin; Piperazine; Piperazines; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections | 2012 |